Enzolytics Inc (ENZC)

[foxi]

Identified a partner is different than working with a partner - this sounds like hopes/plans for the future rather than anything concrete. According to that news, a couple of veterinary mAbs are in production (i.e. research samples?) but they aren't tested or monetized yet.

Enzolytics is collaborating with companies to produce monoclonal antibodies for Feline Leukemia Virus (FeLV) and Feline Immunodeficiency Virus (FIV). Enzolytics has already identified a partner for the monoclonal antibodies targeting Feline Leukemia Virus (FeLV) and Feline Immunodeficiency Virus.

https://enzolytics.com/company-news/

Still, the veterinary mAbs a good thing to note. ENZC can probably get them to market faster than human mAbs due to lower regulatory requirements. They'll need to have operating cash in the interim to see it through.

Thanks for your thoughts!

Given the large number of therapeutics being advanced by Enzolytics, the Company is focused on raising the necessary funds for the production and sale in the U.S. and abroad of IPF Immune™, final development of its anti-HIV ITV-1 therapeutic, accelerating the development of multiple monoclonal antibodies for human therapy, and production of animal monoclonal antibodies. The Company’s audit is being finalized, and the Company fully expects to be able to acquire the funding necessary to complete its multiple programs.

.